Prevention & lipidsCohort study

Evaluation of Lipoprotein(a) as a Prognostic Marker of Extracoronary Atherosclerotic Vascular Disease Progression

CirculationPublished

  • Prospective cohort study

Authors' conclusion

High concentrations of Lp(a) are associated with both incident extracoronary atherosclerotic vascular disease and progression to major complications.

Study context

Population
UK Biobank participants with prospectively measured Lp(a)UK Biobank
Participants
460,544 participants
Exposure
Lp(a) concentrations and incident extracoronary atherosclerotic disease and its progression
Outcome
Incident PAD and incident carotid artery stenosis; progression to first major adverse limb event and first stroke
Follow-up
Median 13.6 years

Main finding

As reported in the abstract

Hazard ratio (95% CI)P value
Lp(a) per 75 nmol/Lincident PAD
1.18(1.15–1.20)
P < 0.0001
Lp(a) per 75 nmol/Lincident carotid stenosis
1.17(1.13–1.20)
P < 0.0001

Per 75 nmol/L, as printed

High Lp(a) vs Normal Lp(a) · major adverse limb event among participants with peripheral artery disease (PAD)
risk 1.57 (95% CI 1.14–2.16); P = 0.006
High Lp(a) vs Normal Lp(a) · ischemic stroke among participants with carotid stenosis; not significant
risk 1.40 (95% CI 0.81–2.40); P = 0.228
Incident PAD
6347 (1.4%)
Incident carotid stenosis
1972 (0.43%)
Prevalent PAD progressing to major adverse limb event
196 (2.7%)
Prevalent carotid stenosis progressing to stroke
67 (1.9%)

Observational data: associations, not effects.

Further findings

OutcomeValues
Median Lp(a) concentration by disease statusNo atherosclerotic vascular disease median 19.5 (IQR 7.6–73.5) nmol/L · Incident PAD median 25.3 (IQR 8.3–107.3) nmol/L · Progression to major adverse limb event median 33.3 (IQR 8.7–158.2) nmol/L · Incident carotid stenosis median 29.5 (IQR 8.5–116.3) nmol/L · Carotid stenosis progression to stroke median 37.8 (IQR 11.1–158.3) nmol/L

Median Lp(a) concentration by disease status

Median Lp(a) significantly different vs those without disease

Original publication

Evaluation of Lipoprotein(a) as a Prognostic Marker of Extracoronary Atherosclerotic Vascular Disease Progression. Circulation. Published 28 July 2025. doi:10.1161/circulationaha.124.073579

Summarised from the published abstract; every number is checked against it